Sort
48,018 grants matching “immunotherapy”
Epigenetic and immunologic aspects of neuroendocrine cancers
$1,140,320Nitin Roper · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
GMP MANUFACTURE OF CLINICAL GRADE THERAPEUTIC VACCINE FOR THE TREATMENT OF PATIENTS WITH CHRONIC HBV
$1,140,300Valerian Nakaar · Carogen Corporation · R44 · FY2023 · DK
Immune Function and the Progression to Type 1 Diabetes
$1,140,152Mark A Atkinson · University Of Florida · P01 · FY2007 · AI
Tumor Plasticity
$1,140,000Dario C. Altieri · Wistar Institute · R35 · FY2021 · CA
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer
$1,140,000Reuben J Shaw · Salk Institute For Biological Studies · R35 · FY2024 · CA
Tumor Plasticity
$1,140,000Dario C. Altieri · Wistar Institute · R35 · FY2020 · CA
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer
$1,140,000Reuben J Shaw · Salk Institute For Biological Studies · R35 · FY2025 · CA
Advancing a Glioma Immunotherapy
$1,139,204Dwaine Franklin Emerich · In Cytu, Inc. · R44 · FY2014 · NS
Aerosolized Epigenetic Therapy for Metastatic Lung Cancer
$1,138,913Matthew Reed · Nob Hill Therapeutics, Inc. · R44 · FY2025 · CA
Pediatric AIDS Clinical Trials Group
$1,137,764St. Jude Children'S Research Hospital · U01 · FY2002 · AI
eDyNAmiC - STANFORD
$1,137,403Paul S Mischel · Stanford University · OT2 · FY2023 · CA
Combined radio- and immunotherapy of aggressive NHL
$1,137,221William A. Wegener · Immunomedics, Inc. · R44 · FY2013 · CA
Heterodimeric IL-15 in Cancer Immunotherapy
$1,137,140George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Strategies for improving early detection, diagnosis and treatment of liver cancer
$1,137,130Xin Wei Wang · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
SOUTHEAST PEDIATRIC AIDS CLINICAL TRIALS UNIT
$1,136,202University Of Alabama At Birmingham · U01 · FY2001 · AI
Immune Function and the Progression to Type 1 Diabetes
$1,135,913Mark A Atkinson · University Of Florida · P01 · FY2008 · AI
Radiation-induced molecular targets
$1,135,907Norman Coleman · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Combinational Immunotherapies to Amplify Vaccine Induced Immunity
$1,135,847Elizabeth Marion Jaffee · Johns Hopkins University · U19 · FY2007 · CA
Engineering In Vivo Chimeric Antigen Receptor Macrophages (CARMs) using mRNA-exosomes for Cancer Immunotherapy
$1,135,633Wen Jiang · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Amyloid-Beta Oligomer Selective Immunotherapy for Prodromal or Mild
$1,135,517Jeffrey L Ives · Acumen Pharmaceuticals, Inc. · U01 · FY2019 · AG
Amyloid-Beta Oligomer Selective Immunotherapy for Prodromal or Mild Alzheimer Disease
$1,135,517Eric Siemers · Acumen Pharmaceuticals, Inc. · U01 · FY2019 · AG
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform
$1,135,383Shawn Hingtgen · Univ Of North Carolina Chapel Hill · U01 · FY2023 · TR
Engineered Glioblastoma-specific T cells using Immunostimulatory Photothermal Nanoparticles
$1,135,290Elizabeth E Sweeney · Immunoblue, Llc · R42 · FY2025 · CA
Cloud-Based Bioinformatics for Immune Repertoire Analysis
$1,135,200David Scott Johnson · Gigagen, Inc. · R44 · FY2013 · HG
Relating Drugs to Genotypes to Transform Precision Cancer Therapeutics with Tuba-seq - a Novel, Highly Scalable and Quantitative Preclinical Experimental Oncology Platform
$1,134,487Ian Paul Winters · D2g Oncology, Inc. · R44 · FY2020 · CA